• 21 ساعت پیش

  • 57

  • 01:54

21st ACC 2025 Congress Coverage: DapaTavi Trial

Daily cardiology
0
توضیحات

🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology.

🔸Stay tuned for more insights from the late-breaking trials presented during this magnificent scientific event.


با صدای
دسته بندی‌ها

رده سنی
محتوای تمیز
تگ ها
shenoto-ads
shenoto-ads